Related Experiment Video
Updated: Feb 12, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Toll-Like Receptors, Inflammation, and Calcific Aortic Valve Disease
Carmen García-Rodríguez1,2, Iván Parra-Izquierdo1, Irene Castaños-Mollor1
1Instituto de Biología y Genética Molecular, CSIC-Universidad de Valladolid, Valladolid, Spain.
Insights
Inflammation initiates calcific aortic valve disease (CAVD). Toll-like receptor (TLR) signaling drives this inflammation and subsequent valve damage, suggesting TLRs as potential therapeutic targets for CAVD.
Area of Science:
- Immunology
- Cardiovascular Biology
- Pathology
Background:
- Calcific aortic valve disease (CAVD) is a prevalent valvulopathy in Western countries.
- CAVD pathogenesis involves inflammation, hemodynamic factors, fibrosis, and calcification.
- Both innate and adaptive immune responses are activated in CAVD development.
Purpose of the Study:
- To review the association between Toll-like receptor (TLR) signaling and inflammation in CAVD pathogenesis.
- To highlight the role of TLRs in the initiation and progression of fibrocalcific remodeling.
- To explore TLR signaling as a potential therapeutic target for CAVD.
Main Methods:
- Literature review of current notions on TLR signaling in CAVD.
- Analysis of recent data on inflammatory and osteogenic responses in CAVD.
- Synthesis of evidence supporting inflammation's mechanistic role in CAVD.
Main Results:
- Inflammation is essential for initiating CAVD calcification.
- Toll-like receptors (TLRs) are key mediators of inflammation in CAVD.
- TLR signaling contributes to fibrocalcific remodeling and disease progression.
Conclusions:
- Inflammation, particularly via TLR signaling, plays a central role in CAVD pathogenesis.
- TLR-mediated inflammatory and osteogenic responses are crucial in CAVD.
- Targeting TLR signaling offers a potential therapeutic strategy for CAVD.
Abstract:
Inflammation, the primary response of innate immunity, is essential to initiate the calcification process underlying calcific aortic valve disease (CAVD), the most prevalent valvulopathy in Western countries. The pathogenesis of CAVD is multifactorial and includes inflammation, hemodynamic factors, fibrosis, and active calcification. In the development of CAVD, both innate and adaptive immune responses are activated, and accumulating evidences show the central role of inflammation in the initiation and propagation phases of the disease, being the function of Toll-like receptors (TLR) particularly relevant. These receptors act as sentinels of the innate immune system by recognizing pattern molecules from both pathogens and host-derived molecules released after tissue damage. TLR mediate inflammation via NF-κB routes within and beyond the immune system, and play a crucial role in the control of infection and the maintenance of tissue homeostasis. This review outlines the current notions about the association between TLR signaling and the ensuing development of inflammation and fibrocalcific remodeling in the pathogenesis of CAVD. Recent data provide new insights into the inflammatory and osteogenic responses underlying the disease and further support the hypothesis that inflammation plays a mechanistic role in the initiation and progression of CAVD. These findings make TLR signaling a potential target for therapeutic intervention in CAVD.
More Related Videos
Related Concept Videos
Inflammation
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Internal Receptors
Mitral Valve Prolapse I: Introduction
Receptor-mediated Endocytosis
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...

